Noninvasive assessment of liver fibrosis

By S. M. Martínez, G. Crespo, M. Navasa, X. Forns. Hepatology, 2011

715 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012, background): “In this respect, transient elastography appears to be a promising tool able to stratify patients at different HCC risks [14,60].”
WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. (2015, background): “There are many reports on the use of blood markers for liver fibrosis, such as platelets, hyaluronic acid, type IV collagen, aminotransferase/platelet ratio index (APRI), and algorithm-based serum models (such as Fibro Index, FIB-4, and Fibro Test) (Martinez et al. 2011a).”
Magnetic Resonance Elastography of Liver: Technique, Analysis and Clinical Applications (2013, background): “Patients with fibrosis that has progressed to cirrhosis are recommended to undergo screening for hepatocellular carcinoma and varices (11).”
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012, background): “In this respect, transient elastography appears to be a promising tool able to stratify patients at differentHCC risks [14,60].”
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017, background): “Noninvasive methods to ascertain liver fibrosis, such as transient elastography (TE), appear to be novel tools to stratify patients at different HCC risks [401].”